BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8156789)

  • 1. Aggravation of herpetic stromal keratitis after murine epidermal grown factor topical application.
    Romano A; Peisich A; Wasserman D; Gamus D
    Cornea; 1994 Mar; 13(2):167-72. PubMed ID: 8156789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of cobalt chelates in the rabbit eye model for epithelial herpetic keratitis.
    Asbell PA; Epstein SP; Wallace JA; Epstein D; Stewart CC; Burger RM
    Cornea; 1998 Sep; 17(5):550-7. PubMed ID: 9756451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large Amounts of Reactivated Virus in Tears Precedes Recurrent Herpes Stromal Keratitis in Stressed Rabbits Latently Infected with Herpes Simplex Virus.
    Perng GC; Osorio N; Jiang X; Geertsema R; Hsiang C; Brown D; BenMohamed L; Wechsler SL
    Curr Eye Res; 2016; 41(3):284-91. PubMed ID: 25859798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cidofovir and experimental herpetic stromal disease.
    Kaufman HE; Varnell ED; Thompson HW
    Arch Ophthalmol; 1999 Jul; 117(7):925-8. PubMed ID: 10408458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderation of herpetic stromal keratitis by basic fibroblast growth factor.
    Gamus D; Romano A; Rubinstein M; Savion N
    Exp Eye Res; 1996 Jul; 63(1):1-8. PubMed ID: 8983954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latanoprost increases the severity and recurrence of herpetic keratitis in the rabbit.
    Kaufman HE; Varnell ED; Thompson HW
    Am J Ophthalmol; 1999 May; 127(5):531-6. PubMed ID: 10334345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of FGF-2 to modulate herpetic stromal keratitis.
    Kim B; Lee S; Kaistha SD; Rouse BT
    Curr Eye Res; 2006 Dec; 31(12):1021-8. PubMed ID: 17169840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis. The Epithelial Keratitis Trial. The Herpetic Eye Disease Study Group.
    Arch Ophthalmol; 1997 Jun; 115(6):703-12. PubMed ID: 9194719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal keratitis induced by a unique clinical isolate of herpes simplex virus type 1.
    Sakai Y; Minagawa H; Ishibashi T; Inomata H; Mori R
    Ophthalmologica; 1994; 208(3):157-60. PubMed ID: 8065701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus latency in human cornea.
    Shimomura Y; Mori Y; Inoue Y; Kiritooshi A; Ohashi Y; Manabe R
    Jpn J Ophthalmol; 1993; 37(3):318-24. PubMed ID: 8295371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of topical cyclosporin A on herpetic stromal keratitis in a mouse model.
    Yoon KC; Heo H; Kang IS; Lee MC; Kim KK; Park SH; Cho KO
    Cornea; 2008 May; 27(4):454-60. PubMed ID: 18434850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of HSV-1 stromal keratitis with topical cyclosporin A: a pilot study.
    Heiligenhaus A; Steuhl KP
    Graefes Arch Clin Exp Ophthalmol; 1999 May; 237(5):435-8. PubMed ID: 10333113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical treatment with nerve growth factor in an animal model of herpetic keratitis.
    Lambiase A; Coassin M; Costa N; Lauretti P; Micera A; Ghinelli E; Aloe L; Rama P; Bonini S
    Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):121-7. PubMed ID: 17479276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical administration of HSV gD-IL-2 DNA is highly protective against murine herpetic stromal keratitis.
    Inoue T; Inoue Y; Hayashi K; Yoshida A; Nishida K; Shimomura Y; Fujisawa Y; Aono A; Tano Y
    Cornea; 2002 Jan; 21(1):106-10. PubMed ID: 11805518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The severity of herpes simplex viral keratitis in mice does not reflect the severity of disease in humans.
    Rinne JR; Abghari SZ; Stulting RD
    Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):268-72. PubMed ID: 1310955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Battle with herpes for 37 years].
    Shimomura Y
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):145-66; discussion 167. PubMed ID: 25854108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo effects of polyhexamethylene biguanide against herpes simplex virus infection.
    Valluri S; Fleming TP; Laycock KA; Tarle IS; Goldberg MA; Garcia-Ferrer FJ; Essary LR; Pepose JS
    Cornea; 1997 Sep; 16(5):556-9. PubMed ID: 9294689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased severity of herpes simplex virus type 1-induced keratitis in Hox A5 transgenic mice.
    Galle LE; Taus NS; Maggs DJ; Moore CP; Mitchell WJ
    Curr Eye Res; 2001 Dec; 23(6):435-42. PubMed ID: 12045893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
    Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staining characteristics and antiviral activity of sulforhodamine B and lissamine green B.
    Chodosh J; Dix RD; Howell RC; Stroop WG; Tseng SC
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1046-58. PubMed ID: 7510270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.